{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:24:23Z","timestamp":1791937463532,"version":"4.3.4"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s00482-012-1216-7","type":"journal-article","created":{"date-parts":[[2012,9,11]],"date-time":"2012-09-11T07:24:00Z","timestamp":1347348240000},"page":"500-514","source":"Crossref","is-referenced-by-count":14,"title":["Behandlung von \u00dcbelkeit und Erbrechen mit Prokinetika und Neuroleptika bei Palliativpatienten","Treatment of nausea and vomiting with prokinetics and neuroleptics in palliative care patients"],"prefix":"10.1007","volume":"26","author":[{"given":"G.","family":"Benze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Alt-Epping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Nauck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,14]]},"reference":[{"key":"1216_CR1","unstructured":"Twycross R, Lack SA (1986) Nausea and vomiting. In: Control of alimentary symptoms in far advanced cancer. Churchill Livingstone, Edinburgh, pp\u00a0117\u2013165"},{"key":"1216_CR2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/026921639000400108","volume":"4","author":"Dunlop","year":"1989","unstructured":"Dunlop GM (1989) A study of the relative frequency and importance of gastrointestinal symptoms, and weakness in patients with far advanced cancer. Palliat Med 4:37\u201343","journal-title":"Palliat Med"},{"key":"1216_CR3","first-page":"5","volume":"7","author":"Fainsinger","year":"1991","unstructured":"Fainsinger R, Miller M, Bruera E et al (1991) Symptom control during the last week of life on a palliative care unit. J Palliat Care 7(1):5\u201311","journal-title":"J Palliat Care"},{"key":"1216_CR4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0885-3924(94)90174-0","volume":"9","author":"Grond","year":"1994","unstructured":"Grond S, Zech D, Diefenbach C, Bischoff A (1994) Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic. J Pain Symptom Manage 9:372\u2013382","journal-title":"J Pain Symptom Manage"},{"key":"1216_CR5","doi-asserted-by":"crossref","unstructured":"Klaschik E (2006) Schmerztherapie und Symptomkontrolle in der Palliativmedizin. In: Huseb\u00f8 S, Klaschik E (Hrsg) Palliativmedizin 4. Aufl., Springer, Berlin Heidelberg New York, S\u00a0203\u2013309","DOI":"10.1007\/3-540-29889-4_4"},{"key":"1216_CR6","unstructured":"Mannix KA (2004) Palliation of nausea and vomiting. In: Doyle D, Hanks G, Cherny N, Calman K (eds) Oxford textbook of palliative medicine. Oxford University Press, Oxford, pp\u00a0459\u2013468"},{"key":"1216_CR7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0885-3924(99)00096-2","volume":"18","author":"Morita","year":"1999","unstructured":"Morita T, Tsunoda J, Inoue S, Chiara S (1999) Contributing factors to physical symptoms in terminally ill cancer patients. J Pain Sympt Manage 18:338\u2013346","journal-title":"J Pain Sympt Manage"},{"key":"1216_CR8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jpainsymman.2005.06.007","volume":"31","author":"Solano","year":"2006","unstructured":"Solano JP, Gomes B, Higginson IJ (2006) A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Sympt Manage 31(1):58\u201369","journal-title":"J Pain Sympt Manage"},{"key":"1216_CR9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0885-3924(96)00042-5","volume":"12","author":"Vainio","year":"1996","unstructured":"Vainio A, Auvien A (1996) Prevalence of symptoms among patients with advanced cancer: an international collaborative study. J Pain Symptom Manage 12:3\u201310","journal-title":"J Pain Symptom Manage"},{"key":"1216_CR10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/082585979300900204","volume":"9","author":"Lichter","year":"1993","unstructured":"Lichter I (1993) Results of antiemetic management in terminal illess. J Palliat Care 9:19\u201321","journal-title":"J Palliat Care"},{"key":"1216_CR11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1383\/medc.32.4.9.32913","volume":"32","author":"Twycross","year":"2004","unstructured":"Twycross R (2004) Anorexia, cachexia, nausea and vomiting. Medicine 32(4):9\u201313","journal-title":"Medicine"},{"key":"1216_CR12","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0885-3924(91)90041-2","volume":"6","author":"Campora","year":"1991","unstructured":"Campora E, Merlini L, Pace M et al (1991) The incidence of narcotic-induced emesis. J Pain Symptom Manage 6:428\u2013430","journal-title":"J Pain Symptom Manage"},{"key":"1216_CR13","unstructured":"Baines MJ (1993) The pathophysiology and management of malignant intestinal obstruction. In: Doyle D, Hanks GWC, MacDonald N (eds) Oxford textbook of palliative medicine. Oxford University Press, Oxford, pp\u00a0311\u2013315"},{"key":"1216_CR14","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1136\/bmj.315.7116.1148","volume":"315","author":"Baines","year":"1997","unstructured":"Baines MJ (1997) ABC of palliative care \u2013 nausea, vomiting, and intestinal obstruction. BMJ 315:1148\u20131150","journal-title":"BMJ"},{"key":"1216_CR15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1191\/026921601678576239","volume":"15","author":"Bentley","year":"2001","unstructured":"Bentley A, Boyd K (2001) Use of clinical pictures in the management of nausea and vomiting: a prospective audit. Palliat Med 15:247\u2013253","journal-title":"Palliat Med"},{"key":"1216_CR16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/082585979300900108","volume":"9","author":"Lichter","year":"1993","unstructured":"Lichter I (1993) Which antiemetics? J Pall Care 9(1):42\u201350","journal-title":"J Pall Care"},{"key":"1216_CR17","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s00520-004-0629-y","volume":"12","author":"Glare","year":"2004","unstructured":"Glare P, Pereira G, Kristjanson LJ et al (2004) Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer. Support Care Cancer 12:432\u2013440","journal-title":"Support Care Cancer"},{"key":"1216_CR18","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1177\/0269216308096906","volume":"22","author":"Janssen","year":"2008","unstructured":"Janssen DJ, Spruit MA, Wouters EF, Schols JM (2008) Daily symptom burden in end-stage chronic organ faliure: a systematic review. Palliat Med 22:938\u2013948","journal-title":"Palliat Med"},{"key":"1216_CR19","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1001\/archinte.164.21.2321","volume":"164","author":"Walke","year":"2004","unstructured":"Walke LM, Gallo WT, Tinetti ME, Fried TR (2004) The burden of symptoms among community-dwelling older persons with advanced chronic disease. Arch Intern Med 164(22):2321\u20132324","journal-title":"Arch Intern Med"},{"key":"1216_CR20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1191\/026921601678320278","volume":"15","author":"Edmonds","year":"2001","unstructured":"Edmonds P, Karlsen S, Khan S, Addington-Hall J (2001) A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat Med 15:287\u2013295","journal-title":"Palliat Med"},{"key":"1216_CR21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1191\/026921601678320269","volume":"15","author":"Anderson","year":"2001","unstructured":"Anderson H, Ward C, Eardley A et al (2001) The concerns of patients under palliative care and heart failure are not being met. Palliat Med 15:279\u2013286","journal-title":"Palliat Med"},{"key":"1216_CR22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1474-5151(03)00059-8","volume":"2","author":"Nordgren","year":"2003","unstructured":"Nordgren L (2003) Symptoms experienced in the last six months of life in patients with end-stage heart faliure. Eur J Cardiovas Nurs 2:213\u2013217","journal-title":"Eur J Cardiovas Nurs"},{"key":"1216_CR23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ejcnurse.2005.03.010","volume":"4","author":"Zambroski","year":"2005","unstructured":"Zambroski CH, Moser DK, Bhat G, Ziegler C (2005) Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure. Eur J Cadiovasc Nurs 4:198\u2013206","journal-title":"Eur J Cadiovasc Nurs"},{"key":"1216_CR24","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ahj.2004.06.019","volume":"149","author":"Zambroski","year":"2005","unstructured":"Zambroski CH, Moser DK, Roser LP et al (2005) Patients with heart faliure who die in hospice. Am Heart J 149(3):558\u2013564","journal-title":"Am Heart J"},{"key":"1216_CR25","first-page":"1","volume":"420","author":"Grenman","year":"1985","unstructured":"Grenman R (1985) Involvement of the audiovestibular system in multiple sclerosis: an otoneurologic and audiologic study. Acta Otolaryngol Suppl 420:1\u201395","journal-title":"Acta Otolaryngol Suppl"},{"key":"1216_CR26","first-page":"930","volume":"39","author":"Kuba","year":"1999","unstructured":"Kuba H, Arakawa K, Taniwaki T et al (1999) A case of relapsing multiple sclerosis presenting with only autonomic symptoms including orthostatic hypotension, hiccups and vomiting. Rinsho Shinkeigaku 39(9):930\u2013934","journal-title":"Rinsho Shinkeigaku"},{"key":"1216_CR27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/jnnp.59.3.342","volume":"59","author":"Khan","year":"1995","unstructured":"Khan OA, Sandoz GM, Olek MJ, Kuta AJ (1995) Visually induced paroxysmal nausea and vomiting as presenting manifestations of multiple sclerosis. J Neurol Neurosurg Psychiatry 59(3):342\u2013343","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1216_CR28","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jpainsymman.2005.04.011","volume":"30","author":"Karaus","year":"2005","unstructured":"Karaus D, Raveis VH, Alexander C et al (2005) Patient reports of symptoms and their treatment at three pallaitive care projects servicing individuals with HIV\/AIDS. J Pain Symptom Manage 30:408\u2013417","journal-title":"J Pain Symptom Manage"},{"key":"1216_CR29","first-page":"2221","volume":"32","author":"Konturek","year":"1997","unstructured":"Konturek JW, Fischer H, Voort IR van der, Domschke W (1997) Disturbed gastric motor activity in patients with human immuno deficiency virus infection. Scand J Gastroenterol 32:2221\u20132225","journal-title":"Scand J Gastroenterol"},{"key":"1216_CR30","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1258\/ijsa.2008.008244","volume":"19","author":"Chubineh","year":"2008","unstructured":"Chubineh S, McGowan J (2008) Nausea and vomiting in HIV: a symptom review. Int J STD AIDS 19:723\u2013728","journal-title":"Int J STD AIDS"},{"key":"1216_CR31","unstructured":"Hanna L (1997) Nausea and Vomiting. BETA 23\u201326"},{"key":"1216_CR32","unstructured":"Lee M, Feldmann M (1993) Nausea and vomiting. In: Sleisenger MH, Fordtran JS (eds) Gastrointestinal Disease. Asunders, Philadelphia, pp\u00a0509\u2013523"},{"key":"1216_CR33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0006-8993(94)91325-0","volume":"647","author":"Miller","year":"1994","unstructured":"Miller AD (1994) Brain areas essential or non-essential for emesis. Brain Res 647:255\u2013264","journal-title":"Brain Res"},{"key":"1216_CR34","first-page":"39","volume":"5","author":"Twycross","year":"1998","unstructured":"Twycross R, Back I (1998) Nausea and vomiting in advanced cancer. Eur J Palliat Care 5:39\u201345","journal-title":"Eur J Palliat Care"},{"key":"1216_CR35","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.2165\/0003495-200868180-00004","volume":"68","author":"Glare","year":"2008","unstructured":"Glare PA, Dunwoodie D, Clark K et al (2008) Treatment of nausea and vomiting in terminally ill cancer patients. Drugs 68:2575\u20132590","journal-title":"Drugs"},{"key":"1216_CR36","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s00520-005-0897-1","volume":"14","author":"Stephenson","year":"2006","unstructured":"Stephenson J, Davies A (2006) An assessment of aetiology-based guidelines for the management of nausea and vomiting in patients with advanced cancer. Support Care Cancer 14:348\u2013353","journal-title":"Support Care Cancer"},{"key":"1216_CR37","unstructured":"Twycross R (1997) Symptom management in advanced cancer, 2nd edn. Radcliffe Medical Press, Oxford, pp\u00a0188\u2013198"},{"key":"1216_CR38","first-page":"32","volume":"7","author":"Twycross","year":"1999","unstructured":"Twycross R (1999) Guidelines for the management of nausea and vomiting. Palliative Care Today 7:32\u201334","journal-title":"Palliative Care Today"},{"key":"1216_CR39","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1002\/1097-0142(19941215)74:12<3204::AID-CNCR2820741220>3.0.CO;2-G","volume":"74","author":"Bruera","year":"1994","unstructured":"Bruera ED, MacEachern TJ, Spachynski KA et al (1994) Comparison of the efficacy, safety, and pharmacokinetics of controlled release and immediate release metoclopramide for the management of chronic nausea in patients with advanced cancer. Cancer 74(12):3204\u20133211","journal-title":"Cancer"},{"key":"1216_CR40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0885-3924(95)00161-1","volume":"11","author":"Bruera","year":"1996","unstructured":"Bruera E, Seifert L, Watanabe S et al (1996) Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramide-based antiemetic regimen. J Pain Symptom Manage 11:147\u2013153","journal-title":"J Pain Symptom Manage"},{"key":"1216_CR41","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0885-3924(00)00138-X","volume":"19","author":"Bruera","year":"2000","unstructured":"Bruera E, Belzile M, Neumann C et al (2000) A double-blind, cross-over study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. J Pain Symptom Manage 19:427\u2013435","journal-title":"J Pain Symptom Manage"},{"key":"1216_CR42","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/(SICI)1097-0142(19980915)83:6<1214::AID-CNCR22>3.0.CO;2-7","volume":"83","author":"Mystakidou","year":"1998","unstructured":"Mystakidou K, Befon S, Liossi C, Vlachos L (1998) Comparison of the efficacy and safety of tropisetron, metoclopramide, and chlorpromazine in the treatment of emesis associated with far advanced cancer. Cancer 83:1214\u20131223","journal-title":"Cancer"},{"key":"1216_CR43","unstructured":"Doyle D, Hanks GWC, MacDonald N (Hrsg) (2004) Oxford textbook of palliative medicine, 3rd. edn. Oxford University Press, Oxford"},{"key":"1216_CR44","unstructured":"Aulbert E, Nauck F, Radbruch L (Hrsg) (2007) Lehrbuch der Palliativmedizin, 2. Aufl. Schattauer, Stutgart"},{"key":"1216_CR45","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.2010.34.4614","volume":"29","author":"Basch","year":"2011","unstructured":"Basch E, Prestrud AA, Hesketh PJ et al (2011) Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 29(31):4189\u20134198","journal-title":"J Clin Oncol"},{"key":"1216_CR46","doi-asserted-by":"crossref","first-page":"456","DOI":"10.6004\/jnccn.2012.0047","volume":"10","author":"Ettinger","year":"2012","unstructured":"Ettinger DS, Armstrong DK, Barbour S, et al; National Comprehensive Cancer Network (NCCN) (2012) NCCN clinical practice guidelines in oncology: antiemesis. J Natl Compr Canc Netw 10:456\u2013485","journal-title":"J Natl Compr Canc Netw"},{"key":"1216_CR47","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/annonc\/mdq194","volume":"21","author":"Roila","year":"2010","unstructured":"Roila F, Herrstedt J, Aapro M et al (2010) Guidelines update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol 21(5):232\u2013243","journal-title":"Ann Oncol"},{"key":"1216_CR48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1472-6963-5-25","volume":"5","author":"Atkins","year":"2005","unstructured":"Atkins D, Briss PA, Eccles M et al (2005) Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system. BMC Health Serv Res 5(1):25","journal-title":"BMC Health Serv Res"},{"key":"1216_CR49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1378\/chest.129.1.174","volume":"129","author":"Guyatt","year":"2006","unstructured":"Guyatt G, Guttermann D, Baumann MH et al (2006) Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians Task Force. Chest 129:174\u2013181","journal-title":"Chest"},{"key":"1216_CR50","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J et al (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(6):e1000097. DOI\u00a010.1371\/journal.pmed1000097","journal-title":"PLoS Med"},{"key":"1216_CR51","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s005200000218","volume":"9","author":"Mercadante","year":"2001","unstructured":"Mercadante S, Fulfaro F, Casuccio A (2001) The use of corticosteroids in home palliative care. Support Care Cancer 9:386\u2013389","journal-title":"Support Care Cancer"},{"key":"1216_CR52","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1089\/jpm.2005.8.1135","volume":"8","author":"Weschules","year":"2005","unstructured":"Weschules DJ (2005) Tolerability of the compound ABHR in hospice patients. J Pall Med 8(6):1135\u20131143","journal-title":"J Pall Med"},{"key":"1216_CR53","first-page":"CD006938","volume":"10","author":"Dorman","year":"2010","unstructured":"Dorman S et al (2010) Droperidol for treatment of nausea and vomiting in palliative care patients. Cochrane Database Syst Rev 10:CD006938","journal-title":"Cochrane Database Syst Rev"},{"key":"1216_CR54","first-page":"CD006271","volume":"2","author":"Perkins","year":"2010","unstructured":"Perkins P, Dorman S (2010) Haloperidol for the treatment of nausea and vomiting in palliative care patients. Cochrane Database Syst Rev 2: CD006271","journal-title":"Cochrane Database Syst Rev"},{"key":"1216_CR55","unstructured":"Malagelada JR, Malagelada C (2006) Nausea and vomiting. In: Feldmann M, Friedman LS, Brandt LJ (eds) Sleisenger & Fortran\u2019s gastrointestinal and liver diesease, 8th edn. Saunders, Philadelphia\/PA, pp\u00a0143\u2013158"},{"key":"1216_CR56","first-page":"1121","volume":"71","author":"Bruera","year":"1987","unstructured":"Bruera E, Brenneis C, Michaud M, MacDonald N (1987) Continuous sc infusion of metoclopramide for treatment of narcotic bowel syndrome. Cancer Treat Rep 71(11):1121\u20131122","journal-title":"Cancer Treat Rep"},{"key":"1216_CR57","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jpainsymman.2004.01.009","volume":"28","author":"Bruera","year":"2004","unstructured":"Bruera E, Moyano JR, Sala R et al (2004) Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: a randomized controlled trial. J Pain Sympt Manage 28(4):381\u2013388","journal-title":"J Pain Sympt Manage"},{"key":"1216_CR58","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/082585970201800203","volume":"18","author":"Wilson","year":"2002","unstructured":"Wilson J, Plourde JY, Marshall D et al (2002) Long-term safety and clinical effectiveness of controlled-release metoclopramide in cancer-associated dyspepsia syndrome: a multicentre evaluation. J Pall Care 18(2):84\u201391","journal-title":"J Pall Care"},{"key":"1216_CR59","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0885-3924(95)00105-8","volume":"10","author":"Corli","year":"1995","unstructured":"Corli O, Cozzolino A, Battaiotto L (1995) Effectiveness of levosulpiride versus metoclopramide for nausea and vomiting in advanced cancer patients: a double-blind, randomized, crossover study. J Pain Symptom Manage 10(7):521\u2013526","journal-title":"J Pain Symptom Manage"},{"key":"1216_CR60","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00520-001-0332-1","volume":"10","author":"Hardy","year":"2002","unstructured":"Hardy J, Daly S, McQuade B et al (2002) A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24\u00a0mg p.\u00a0o. with placebo and metoclopramide 10\u00a0mg t.d.s. p.\u00a0o. in the treatment of opioid-induced nausea and emesis in cancer patients. Support Care Cancer 10:231\u2013236","journal-title":"Support Care Cancer"},{"key":"1216_CR61","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/1049909108315909","volume":"25","author":"Kumar","year":"2008","unstructured":"Kumar G, Hayes KA, Clark R (2008) Efficacy of a scheduled IV cocktail of antiemetics for the palliation of nausea and vomiting in a hospice population. Am J Hosp Palliat Care 25:184\u2013189","journal-title":"Am J Hosp Palliat Care"},{"key":"1216_CR62","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1634\/theoncologist.2-5-319","volume":"2","author":"Mystakidou","year":"1997","unstructured":"Mystakidou K, Befon S, Trifyllis J et al (1997) Tropisetron versus metoclopramide in the control of emesis in far-advanced cancer. Oncologist 2:319\u2013323","journal-title":"Oncologist"},{"key":"1216_CR63","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jpainsymman.2009.08.010","volume":"39","author":"Davis","year":"2010","unstructured":"Davis MP, Hallerberg G (2010) A systematic review of the treatment of nausea and\/or vomiting in cancer unrelated to chemotherapy or radiation. J Pain Symptom Manage 39(4):756\u2013767","journal-title":"J Pain Symptom Manage"},{"key":"1216_CR64","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0885-3924(01)00323-2","volume":"22","author":"Critchley","year":"2001","unstructured":"Critchley P, Plach N, Grantham M et al (2001) Efficacy of haloperidol in the treatment of nausea and vomiting in the palliative patient: a systematic review. J Pain Symptom Manage 22:631\u2013634","journal-title":"J Pain Symptom Manage"},{"key":"1216_CR65","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s005200000151","volume":"8","author":"Davis","year":"2000","unstructured":"Davis MP, Walsh D (2000) Treatment of nausea and vomiting in advanced cancer. Support Care Cancer 8:444\u2013452","journal-title":"Support Care Cancer"},{"key":"1216_CR66","unstructured":"Watson M, Lucas CF, Hoy AM, Back IN (2005) Oxford handbook of palliative care. Oxford University Press, Oxford, pp\u00a0246\u2013253"},{"key":"1216_CR67","unstructured":"Woodruff R (2004) Palliative medicine, 4th edn. Oxford University Press, Oxford, pp\u00a0223\u2013232"},{"key":"1216_CR68","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jpainsymman.2009.11.321","volume":"40","author":"Hardy","year":"2010","unstructured":"Hardy JR, O\u2019Shea A, White C et al (2010) The efficacy of haloperidol in the management of nausea and vomiting in patients with cancer. J Pain Symptom Manage 40(1):111\u2013116","journal-title":"J Pain Symptom Manage"},{"key":"1216_CR69","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0885-3924(94)90147-3","volume":"9","author":"Cole","year":"1994","unstructured":"Cole RM, Robinson F, Harvey L et al (1994) Successful control of intractable nausea and vomiting requiring combined ondansetron and haloperidol in a patient with advanced cancer. J Pain Symptom Manage 9(1):48\u201350","journal-title":"J Pain Symptom Manage"},{"key":"1216_CR70","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0140-6736(85)90534-3","volume":"2","author":"Baines","year":"1985","unstructured":"Baines M, Oliver DJ, Carter RL (1985) Medical management of intestinal obstruction in patients with advanced malignant disease. Lancet 2(8462):990\u2013993","journal-title":"Lancet"},{"key":"1216_CR71","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/030089169007600417","volume":"76","author":"Ventafridda","year":"1990","unstructured":"Ventafridda V, Ripamonti C, Caraceni A et al (1990) The management of inoperable gastrointetsinal obstruction in terminal cancer patients. Tumori 76:389\u2013393","journal-title":"Tumori"},{"key":"1216_CR72","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/109662103764978506","volume":"6","author":"Jackson","year":"2003","unstructured":"Jackson WC, Tavernier L (2003) Olanzapine for intractable nausea in palliative care patients. J Palliat Med 6(2):251\u2013255","journal-title":"J Palliat Med"},{"key":"1216_CR73","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0885-3924(02)00391-3","volume":"23","author":"Passik","year":"2002","unstructured":"Passik SD, Lundberg J, Kirsh KL et al (2002) A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain. J Pain Symptom Manage 23(6):526\u2013532","journal-title":"J Pain Symptom Manage"},{"key":"1216_CR74","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/082585970402000209","volume":"20","author":"Amesbury","year":"2004","unstructured":"Amesbury B, Alloway L, Hickmore E, Dewhurst G (2004) High-dose levopromazine (methotrimeprazine) to control nausea in carcinoid syndrome. J Palliat Care 20(2):117\u2013118","journal-title":"J Palliat Care"},{"key":"1216_CR75","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1191\/0269216305pm972oa","volume":"19","author":"Eisenchlas","year":"2005","unstructured":"Eisenchlas JH, Garrigue N, Junin M, De Simone GG (2005) Low-dose levomepromazine in refractory emesis in advanced cancer patients: an open-label study. Palliat Med 19:71\u201375","journal-title":"Palliat Med"},{"key":"1216_CR76","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00520-004-0768-1","volume":"13","author":"Kennett","year":"2004","unstructured":"Kennett A, Hardy J, Shah S, A\u2019Hern R (2004) An open study of methotrimeprazine in the management of nausea and vomiting in patients with advanced cancer. Support Care Cancer 13:715\u2013721","journal-title":"Support Care Cancer"},{"key":"1216_CR77","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/09699260.1997.12098230","volume":"5","author":"Twycross","year":"1997","unstructured":"Twycross R (1997) The use of low dose levomepromazine (methotrimeprazine) in the management of nausea and vomiting. Prog Palliate Care 5(2):49\u201353","journal-title":"Prog Palliate Care"},{"key":"1216_CR78","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0885-3924(97)00349-7","volume":"15","author":"Mystakidou","year":"1998","unstructured":"Mystakidou K, Befon S, Liossi C, Vlachos L (1998) Comparison of tropisetron and chlorpromazine combinations in the control of nausea and vomiting in patients with advanced cancer. J Pain Symptom Manage 15(3):176\u2013184","journal-title":"J Pain Symptom Manage"},{"key":"1216_CR79","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/104990910602300211","volume":"23","author":"Weschules","year":"2006","unstructured":"Weschules DJ, Maxwell T, Reifsnyder J, Knowlton CH (2006) Are newer, more expensive pharmacotherapy options associated with superior symptom control compared to less costly agents used in a collaborative practice setting? Am J Hosp Palliat Care 23:135\u2013149","journal-title":"Am J Hosp Palliat Care"},{"key":"1216_CR80","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0447.1997.tb05956.x","volume":"391","author":"Nutt","year":"1997","unstructured":"Nutt D (1997) Mirtazapin: pharmacology in relation to adverse effects. Acta Psychiatr Scand 391:31\u201337","journal-title":"Acta Psychiatr Scand"},{"key":"1216_CR81","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00404-005-0007-0","volume":"272","author":"Guclu","year":"2005","unstructured":"Guclu S, Gol M, Dogan E, Saygili U (2005) Mirtazapine use in resistant hyperemesis gravidarum: report of three cases and review of the literature. Arch Gynecol Obstet 272:298\u2013300","journal-title":"Arch Gynecol Obstet"},{"key":"1216_CR82","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1176\/appi.psy.47.5.440","volume":"47","author":"Kim","year":"2006","unstructured":"Kim SW, Shin IS, Kim JM et al (2006) Mirtazapin for severe gastroparesis unresponsive to conventional prokinetic treatment. Psychosomatics 47:440\u2013442","journal-title":"Psychosomatics"},{"key":"1216_CR83","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.pnpbp.2006.03.015","volume":"30","author":"Pae","year":"2006","unstructured":"Pae CU (2006) Low-dose mirtazapin may be successfull treatment option for severe nausea and vomiting. Prog Neuropsychopharmacol Biol Psychiatry 30:1143\u20131145","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1216_CR84","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1381\/0960892053923923","volume":"15","author":"Teixeira","year":"2005","unstructured":"Teixeira FV, Novaretti TM, Pilon B et al (2005) Mirtazapine (Remeron) as treatment for non-mechanical vomiting after gastric bapass. Obes Surg 15:707\u2013709","journal-title":"Obes Surg"},{"key":"1216_CR85","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0885-3924(02)00381-0","volume":"23","author":"Theobald","year":"2002","unstructured":"Theobald DE, Kirsh KL, Holtsclaw E et al (2002) An open-label, cross-over trial of mirtazapine (15\u00a0mg and 30\u00a0mg) in cancer patients with pain and other dirstressing symptoms. J Pain Symptom Manage 23:442\u2013447","journal-title":"J Pain Symptom Manage"},{"key":"1216_CR86","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1176\/appi.psy.41.4.356","volume":"41","author":"Thomson","year":"2000","unstructured":"Thomson DS (2000) Mirtazapine for the treatment of depression and nausea in breast and gynecological oncology. Psychosomatics 41:356\u2013359","journal-title":"Psychosomatics"},{"key":"1216_CR87","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1192\/S0007125000298486","volume":"168","author":"Spiegel","year":"1996","unstructured":"Spiegel D (1996) Cancer and depression. Br J Psychiatry 168:109\u2013116","journal-title":"Br J Psychiatry"},{"key":"1216_CR88","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jpainsymman.2006.10.020","volume":"34","author":"Okamoto","year":"2007","unstructured":"Okamoto Y, Tsuneto S, Matsuda Y et al (2007) A retrospective chart review of the antiemetic effectiveness of risperidone in refractory opioid-induced nausea and vomiting in advanced cancer patients. J Pain Symptom Manage 34(2):217\u2013222","journal-title":"J Pain Symptom Manage"},{"key":"1216_CR89","first-page":"307","volume":"71","author":"Bateman","year":"1989","unstructured":"Bateman DN, Darling WM, Boys R, Rawlins MD (1989) Extrapyramidal reactions to metoclopramide and prochlorperazine. Q J Med 71(264):307\u2013311","journal-title":"Q J Med"},{"key":"1216_CR90","first-page":"349","volume":"A","author":"Breitbart","year":"1990","unstructured":"Breitbart W, Marotta R, Platt M et al (1990) Extrapyramidal symptoms in medically hospitalizes AIDS patients receiving neuroleptics. Abstracts from VIth International AIDS conference A:349 (abstract)","journal-title":"Abstracts from VIth International AIDS conference"},{"key":"1216_CR91","first-page":"69","volume":"8","author":"Connolly","year":"1992","unstructured":"Connolly S, Manji H, Sweeney B et al (1992) Movement disorders in AIDS. Int Conf AIDS 8:69 (abstract no. PuB 7120)","journal-title":"Int Conf AIDS"},{"key":"1216_CR92","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0022-510X(94)90144-9","volume":"127","author":"Factor","year":"1994","unstructured":"Factor SA, Podskalny GD, Barron KD (1994) Persistent neuroleptic-induced rigidity and dystonia in AIDS dementia complex: a clinico-pathological case report. J Neurol Sci 127:114\u2013120","journal-title":"J Neurol Sci"},{"key":"1216_CR93","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/archinte.1993.00410120051007","volume":"153","author":"Ganzini","year":"1993","unstructured":"Ganzini L, Casey DE, Hoffman WF, McCall AL (1993) The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Arch Intern Med 153(12):1469\u20131475","journal-title":"Arch Intern Med"},{"key":"1216_CR94","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0140-6736(85)92706-0","volume":"2","author":"Hollander","year":"1985","unstructured":"Hollander H, Golden J, Mendelson T, Cortland D (1985) Extrapyramidal symptoms in AIDS patients given low-dose metoclopramide or chlorpromazine. Lancet 2(8465):1186","journal-title":"Lancet"},{"key":"1216_CR95","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1176\/ajp.148.11.1558","volume":"148","author":"Hriso","year":"1991","unstructured":"Hriso E, Kuhn T, Masdeu JC, Grundman M (1991) Extrapyramidal symptoms due to dopaminergic blocking agents in patients with AIDS encephalopathy. Am J Psychiatry 148:1558\u20131561","journal-title":"Am J Psychiatry"},{"key":"1216_CR96","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/104990919501200605","volume":"12","author":"Kemp","year":"1995","unstructured":"Kemp C, Stepp L (1995) Palliative care for patients with aquired immunodeficiency syndrome. Am J Hosp Palliat Care 12:14\u201327","journal-title":"Am J Hosp Palliat Care"},{"key":"1216_CR97","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/archinte.1989.00390110070015","volume":"149","author":"Miller","year":"1989","unstructured":"Miller LG, Jankovic J (1989) Metoclopramide-induced movement disorders: clinical findings and a review of the literature. Arch Intern Med 149(11):2486\u20132492","journal-title":"Arch Intern Med"},{"key":"1216_CR98","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/archinte.162.3.358","volume":"162","author":"Kleij","year":"2002","unstructured":"Kleij FG van der, Vries PA de, Stassen PM et al (2002) Acute dystonia due to metoclopramide: increased risk in AIDS. Arch Intern Med 162:358\u2013359","journal-title":"Arch Intern Med"},{"key":"1216_CR99","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s005200000198","volume":"9","author":"Ripamonti","year":"2001","unstructured":"Ripamonti C, Twycross R, Baines M et al (2001) Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer 9:223\u2013233","journal-title":"Support Care Cancer"},{"key":"1216_CR100","first-page":"259","volume":"43","author":"Frank","year":"1997","unstructured":"Frank C (1997) Medical management of intestinal obstruction in terminal care. Can Fam Physician 43:259\u2013265","journal-title":"Can Fam Physician"},{"key":"1216_CR101","first-page":"171","volume":"23","author":"Fallon","year":"1994","unstructured":"Fallon MT, Hanks GW (1994) Control of common symptoms in advanced cancer. Ann Acad Med Singapore 23(2):171\u2013177","journal-title":"Ann Acad Med Singapore"},{"key":"1216_CR102","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/0269216311404273","volume":"25","author":"Laugsand","year":"2011","unstructured":"Laugsand EA, Kaasa S, Klepstad P (2011) Management of opioid-induced nausea and vomiting in cancer patients: systematic review and evidence-based recommendations. Palliat Med 25:442\u2013453","journal-title":"Palliat Med"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-012-1216-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00482-012-1216-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-012-1216-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T17:21:48Z","timestamp":1643390508000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00482-012-1216-7"}},"subtitle":["Ein Review","A review"],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":102,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["1216"],"URL":"https:\/\/doi.org\/10.1007\/s00482-012-1216-7","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"value":"0932-433X","type":"print"},{"value":"1432-2129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}